Skip to main content
. Author manuscript; available in PMC: 2016 Jul 11.
Published in final edited form as: Lancet. 2015 May 7;386(9989):154–162. doi: 10.1016/S0140-6736(14)61774-8

Table 2. Prevalence (%) of Baseline Characteristics in Individuals with New Onset Atrial Fibrillation.

No. atrial fibrillation Decade P for Trend Trend Direction
1958-1967 1968-1977 1978-1987 1988-1997 1998-2007
70 178 284 399 434
Current smoking 27(40•9) 35(22•3) 60(21•7) 62(15•6) 55(12•7) 0•0002
Alcohol consumption
 None 25(42•4) 53(31•7) 127(46•7) 168(42•7) 186(44•0) 0•64 -
 Mild 28(47•5) 92(55•1) 122(44•9) 200(50•9) 214(50•6) 0•28 -
 Moderate or heavy 6(10•2) 22(13•2) 23(8•5) 25(6•4) 23(5•4) 0•005
Body mass index, kg/m2
 Normal, <25 20(30•3) 56(35•7) 107(39•9) 115(30•4) 105(27•7) 0•0009
 Overweight, 25 to <30 28(42•4) 68(43•3) 101(37•7) 173(45•8) 140(36•9) 0•42 -
 Obese, ≥30 18(27•3) 33(21•0) 60(22•4) 90(23•8) 134(35•4) <0•0001
Systolic blood pressure, mm Hg
 Optimal, <120 20(30•3) 56(35•7) 107(39•9) 115(30•4) 105(27•7) <0•0001
 Normal, 120-129 28(42•4) 68(43•3) 101(37•7) 173(45•8) 140(36•9) 0•001
 High-normal 130-139 18(27•3) 33(21•0) 60(22•4) 90(23•8) 134(35•4) 0•009
 Stage I hypertension, 140-159 20(30•3) 56(35•7) 107(39•9) 115(30•4) 105(27•7) 0•001
 Stage II-IV hypertension ≥160 28(42•4) 68(43•3) 101(37•7) 173(45•8) 140(36•9) <0•0001
Hypertension treatment 15(22•1) 55(32•9) 135(47•7) 219(55•4) 257(59•8) <0•0001
Diabetes 4(5•7) 25(14•0) 44(15•7) 66(16•7) 80(19•6) 0•004
Electrocardiographic left ventricular hypertrophy 9(12•9) 21(11•8) 19(6•9) 23(6•2) 12(2•9) <0•0001
Significant heart murmur 14(20•0) 32(18•9) 52(19•2) 42(10•7) 31(8•1) <0•0001
Prevalent heart failure 4(5•7) 15(8•4) 17(6•0) 23(5•8) 15(3•5) 0•009
Prevalent myocardial infarction 6(8•6) 16(9•0) 27(9•5) 45(11•3) 47(10•8) 0•27 -

All entries are in percentages.

In total 1365 (88•4%) atrial fibrillation cases were identified with index exams. The remaining 179 were excluded from this analysis for missing eligible index exams.

This table presents the age- and sex-adjusted prevalence of baseline characteristics for atrial fibrillation cases with index examination. For each characteristic, prevalence in different decades are predicted values from a logistic model where the characteristic is the outcome variable, decade as main predictor if the trend test is significant, with age and sex as covariates. The observed prevalence by sex is presented in Supplementary Table 2.

P-values are obtained from logistic models adjusting for age and sex fitted on observed data.

The prevalence may not add up to exactly 1 for multiple categorical variables because of rounding.

HHS Vulnerability Disclosure